Sak 03807 O Vedlegg Fagleg Rapportering 2006 - Helse Vest

361Olsnes AM, Motorin D, Ryningen A, Zaritskey AY, Bruserud Ø"T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): localrelease by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC)."Cancer Immunol Immunother. 2006;55(7):830-40PMID: 16267679Lønning PE, Børresen-Dale AL"Interaction between p53 staining and high-dose chemotherapy in breast cancer."Clin Cancer Res. 2006;12(7 Pt 1):2289PMID: 16609046Oveland E, Fladmark KE, Wergeland L, Gjertsen BT, Hovland R"Proteomics approaches to elucidate oncogenic tyrosine kinase signaling in myeloidmalignancies."Curr Pharm Biotechnol. 2006;7(3):185-98PMID: 16789903Bergamaschi A, Kim YH, Wang P, Sørlie T, Hernandez-Boussard T, Lonning PE, Tibshirani R, Børresen-Dale AL, Pollack JR"Distinct patterns of DNA copy number alteration are associated with differentclinicopathological features and gene-expression subtypes of breast cancer."Genes Chromosomes Cancer. 2006;45(11):1033-40PMID: 16897746Apelseth TO, Hervig TA, Wentzel-Larsen T, Bruserud O"Cytokine accumulation in photochemically treated and gamma-irradiated plateletconcentrates during storage."Transfusion. 2006;46(5):800-10PMID: 16686848Samuelsson J, Hasselbalch H, Bruserud O, Temerinac S, Brandberg Y, Merup M, Linder O, Bjorkholm M, Pahl HL, Birgegard G,Nordic Study Group for Myeloproliferative Disorders"A phase II trial of pegylated interferon alpha-2b therapy for polycythemiavera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on qualityof life."Cancer. 2006;106(11):2397-405PMID: 16639737Kristensen N, Tsalenko A, Geisler J, Faldaas A, Grenaker G, Lingjaerde OC, Fjeldstad S, Yakhini Z, Lonning PE, Borresen-Dale AL"Multilocus analysis of SNP and metabolic data within a given pathway."BMC Genomics. 2006;7(1):5PMID: 16412218Anensen N, Haaland I, D'Santos C, Van Belle W, Gjertsen BT"Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia."Curr Pharm Biotechnol. 2006;7(3):199-207PMID: 167899042 doktorgrader er avlagt i 2006:Huszthy PC"Studies on viral gene transfer and angiogenesis inhibition in experimental glioma models"November 2006Hovedveileder: Rolf Bjerkvig og Per Eystein LønningÅnensen N"p53 protein biosignatures in acute myeloid leukemia"Mars 2006Hovedveileder: Bjørn Tore Gjertsen5 forskningsbiobanker er tilknyttet prosjektet:ID: 114 (FHI Biobankregisteret)"Blod og tumormateriale for undersøkelse av virknings- og resistensmekanismer for cellegift og hormonbehandling ved ulikekreftformer."Ansvarlig institusjon: Helse Bergen HFAnsvarshavende: Lønning PEEtablert i 2000Translasjonsforskning - Oncogenesis & Cancer Research